Skip to main content
Clinical Trials/NCT01397396
NCT01397396
Completed
Phase 3

Effects of Inspiratory Muscle Training in Patients With Chronic Obstructive Pulmonary Disease - a Randomized Controlled Trial

KU Leuven1 site in 1 country208 target enrollmentFebruary 2012

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
COPD
Sponsor
KU Leuven
Enrollment
208
Locations
1
Primary Endpoint
6-Minute Walking Distance
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

The additional effect of inspiratory muscle training as an adjunct to a general exercise training program in patients with COPD with inspiratory muscle weakness will be studied. The main hypothesis is that inspiratory muscle training combined with an exercise training program improves functional exercise capacity more than an exercise training program without the addition of an inspiratory muscle training program.

Registry
clinicaltrials.gov
Start Date
February 2012
End Date
December 2016
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
KU Leuven
Responsible Party
Principal Investigator
Principal Investigator

Daniel Langer

Dr Daniel Langer

KU Leuven

Eligibility Criteria

Inclusion Criteria

  • Patients with COPD
  • Eligible to participate in a exercise training intervention of 8 weeks
  • Pi,max \<60cmH2O or \<50% of the predicted normal value

Exclusion Criteria

  • Major comorbidities preventing successful participation in an 8 week exercise training intervention

Outcomes

Primary Outcomes

6-Minute Walking Distance

Time Frame: Baseline and 8 weeks follow-up

Study Sites (1)

Loading locations...

Similar Trials